title: Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis.
abstract: OBJECTIVE
  We evaluated the predictive factors for recurrent restenosis lesions treated on two previous occasions with sirolimus-eluting stents (SES).
  
  
  BACKGROUND
  Angiography data related to recurrent SES restenosis have not been reported.
  
  
  METHODS
  Binary restenosis was observed in 66 patients with 78 lesions from a total of 1,393 patients with 1,965 lesions who received follow-up angiography after SES implantation. We enrolled 55 patients with 67 lesions who underwent revascularization using another SES with a second follow-up coronary angiography. These restenotic lesions were divided into two groups based on the presence or absence of recurrent restenosis: no recurrent restenosis group (n = 56) and recurrent restenosis group (n = 11). The coronary angiography data during first and second SES implantation were compared between the groups.
  
  
  RESULTS
  Minimal lumen diameter (MLD) was smaller before first and second percutaneous coronary interventions (PCI) with SES implantation in the recurrent restenotic group compared with no recurrent restenosis group (first PCI, 0.28 ± 0.19 mm vs. 0.54 ± 0.42 mm, P = 0.040; second PCI, 0.44 ± 0.36 mm vs. 0.69 ± 0.39 mm, P = 0.036, respectively). Acute stent recoil after second SES implantation was significantly greater in the recurrent restenosis group compared with no recurrent restenosis group (0.08 ± 0.17 mm vs. 0.20 ± 0.22 mm, P = 0.049, respectively). Multivariate analysis showed preprocedural MLD at first PCI and acute stent recoil at second PCI as independent predictors of recurrent restenosis.
  
  
  CONCLUSIONS
  Preprocedural smaller MLD at first PCI and acute stent recoil at second PCI are predictors of recurrent restenosis treated on two previous occasions with SES.
authors: Cardiovascular Center, Sakurabashi Watanabe Hospital, Kita-ku, Osaka, Japan. makito@jade.dti.ne.jp
authors: Makito
authors: M
authors: Ozawa
authors: Atsunori
authors: A
authors: Okamura
authors: Motoo
authors: M
authors: Date
authors: Yoshiharu
authors: Y
authors: Higuchi
authors: Hiroyuki
authors: H
authors: Nagai
authors: Masahiko
authors: M
authors: Shibuya
authors: Kimura
authors: K
authors: Ryusuke
authors: Koichi
authors: K
authors: Inoue
authors: Yasushi
authors: Y
authors: Koyama
authors: Katsuomi
authors: K
authors: Iwakura
authors: Kenshi
authors: K
authors: Fujii
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D016009:Chi-Square Distribution; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007564:Japan; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011474:Prosthesis Design; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D020123:Sirolimus / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; D020123:Sirolimus